Zobrazeno 1 - 10
of 582
pro vyhledávání: '"Ronald B. Herberman"'
Autor:
Ashokkumar A. Patel, John R. Gilbertson, Louise C. Showe, Jack W. London, Eric Ross, Michael F. Ochs, Joseph Carver, Andrea Lazarus, Anil V. Parwani, Rajiv Dhir, J. Robert Beck, Michael Liebman, Fernando U. Garcia, Jeff Prichard, Myra Wilkerson, Ronald B. Herberman, Michael J. Becich
Publikováno v:
Cancer Informatics, Vol 3, Pp 255-274 (2007)
Background: The Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC, http://www.pcabc.upmc.edu) is one of the first major project-based initiatives stemming from the Pennsylvania Cancer Alliance that was funded for four years by the Departm
Externí odkaz:
https://doaj.org/article/fdb7df87edda4b72b5535729b2e4a0d0
Autor:
Eva Szabo, Caroline C. Sigman, Samir N. Khleif, Gary J. Kelloff, Olivera Finn, Ronald B. Herberman, Gary Gordon, Dean E. Brenner, Gregory A. Curt, Frank L. Meyskens
This article endeavors to clarify the current requirements and status of regulatory approval for chemoprevention (risk reduction) drugs and discusses possible improvements to the regulatory pathway for chemoprevention. Covering a wide range of topics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fa3f75d71d704b4a7f8b8484b2f7389
https://doi.org/10.1158/1940-6207.c.6544541
https://doi.org/10.1158/1940-6207.c.6544541
Autor:
Eva Szabo, Caroline C. Sigman, Samir N. Khleif, Gary J. Kelloff, Olivera Finn, Ronald B. Herberman, Gary Gordon, Dean E. Brenner, Gregory A. Curt, Frank L. Meyskens
Supplementary Appendices from Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f211a2c1a237431095ca6307a8dddac
https://doi.org/10.1158/1940-6207.22525025
https://doi.org/10.1158/1940-6207.22525025
Autor:
Nikola L. Vujanovic, Eugene N. Myers, Theresa L. Whiteside, Robert L. Ferris, Susanne M. Gollin, Ronald B. Herberman, Jennifer L. Hunt, Miroslaw J. Szczepanski, Dragic Bankovic, Jie Han, Andrea Vujanovic, Toshie Yoneyama, Sebnem Unlu, Lazar Vujanovic, Per Basse, Dejan Baskic, Lisheng Ge
Supplementary Figure 1 from Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a459d39e76bb5399b3b48e8cf9965e
https://doi.org/10.1158/1055-9965.22435521
https://doi.org/10.1158/1055-9965.22435521
Autor:
Nikola L. Vujanovic, Eugene N. Myers, Theresa L. Whiteside, Robert L. Ferris, Susanne M. Gollin, Ronald B. Herberman, Jennifer L. Hunt, Miroslaw J. Szczepanski, Dragic Bankovic, Jie Han, Andrea Vujanovic, Toshie Yoneyama, Sebnem Unlu, Lazar Vujanovic, Per Basse, Dejan Baskic, Lisheng Ge
Tumor necrosis factor α converting enzyme (TACE) is a sheddase overexpressed in cancers that generates cancer cell growth and survival factors, and is implicated in carcinogenesis and tumor growth. This indicates that TACE could be a potentially imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91293291a3fd47ad4ccd66d263c6bb8f
https://doi.org/10.1158/1055-9965.c.6514965.v1
https://doi.org/10.1158/1055-9965.c.6514965.v1
Autor:
Nikola L. Vujanovic, Eugene N. Myers, Theresa L. Whiteside, Robert L. Ferris, Susanne M. Gollin, Ronald B. Herberman, Jennifer L. Hunt, Miroslaw J. Szczepanski, Dragic Bankovic, Jie Han, Andrea Vujanovic, Toshie Yoneyama, Sebnem Unlu, Lazar Vujanovic, Per Basse, Dejan Baskic, Lisheng Ge
Supplementary Figure Legends from Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bb6a9977fdffd82b9291fab0b5b6717
https://doi.org/10.1158/1055-9965.22435512
https://doi.org/10.1158/1055-9965.22435512
Autor:
Nikola L. Vujanovic, Eugene N. Myers, Theresa L. Whiteside, Robert L. Ferris, Susanne M. Gollin, Ronald B. Herberman, Jennifer L. Hunt, Miroslaw J. Szczepanski, Dragic Bankovic, Jie Han, Andrea Vujanovic, Toshie Yoneyama, Sebnem Unlu, Lazar Vujanovic, Per Basse, Dejan Baskic, Lisheng Ge
Supplementary Figure 2 from Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6414d5d0acf5a260183acb75e6cfd98d
https://doi.org/10.1158/1055-9965.22435518.v1
https://doi.org/10.1158/1055-9965.22435518.v1
Autor:
Nikola L. Vujanovic, Eugene N. Myers, Theresa L. Whiteside, Robert L. Ferris, Susanne M. Gollin, Ronald B. Herberman, Jennifer L. Hunt, Miroslaw J. Szczepanski, Dragic Bankovic, Jie Han, Andrea Vujanovic, Toshie Yoneyama, Sebnem Unlu, Lazar Vujanovic, Per Basse, Dejan Baskic, Lisheng Ge
Supplementary Figure 3 from Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11cb072325ef3c1d3bc26b04eabd75b1
https://doi.org/10.1158/1055-9965.22435515.v1
https://doi.org/10.1158/1055-9965.22435515.v1
Autor:
Anna E. Lokshin, Elieser Gorelik, Marta E. Szajnik, Miroslaw J. Szczepanski, Ronald B. Herberman, Larry G. Maxwell, Gil Mor, Jinsong Liu, David Fishman, Andrew K. Godwin, YunYun Su, Brian Nolen, Vera V. Levina
Supplementary Table 1 from Biological Significance of Prolactin in Gynecologic Cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28b236e40f8d6201bc86d4bff9e03644
https://doi.org/10.1158/0008-5472.22379273
https://doi.org/10.1158/0008-5472.22379273
Autor:
Anna E. Lokshin, Elieser Gorelik, Marta E. Szajnik, Miroslaw J. Szczepanski, Ronald B. Herberman, Larry G. Maxwell, Gil Mor, Jinsong Liu, David Fishman, Andrew K. Godwin, YunYun Su, Brian Nolen, Vera V. Levina
There is increasing evidence that prolactin (PRL), a hormone/cytokine, plays a role in breast, prostate, and colorectal cancers via local production or accumulation. Elevated levels of serum PRL in ovarian and endometrial cancers have been reported,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f077bbf6e87dcbef267ebcedd95c998
https://doi.org/10.1158/0008-5472.c.6499202.v1
https://doi.org/10.1158/0008-5472.c.6499202.v1